Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention

Published:2019-11-15 Issue:4 Volume:13 Page:668-675
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Mangiacapra Fabio^ORCID,Bressi Edoardo,Colaiori Iginio,Ricottini Elisabetta,Cavallari Ilaria,Capuano Marialessia,Viscusi Michele Matia,Spoto Silvia,Barbato Emanuele,Di Sciascio Germano

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12265-019-09931-z.pdf

Reference34 articles.

1. Neumann, F. J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., et al. (2019). 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40, 87–165.

2. Redfors, B., Ben-Yehuda, O., Lin, S. H., Furer, A., Kirtane, A. J., Witzenbichler, B., et al. (2017). Quantifying ischemic risk after percutaneous coronary intervention attributable to high platelet reactivity on Clopidogrel (from the assessment of dual antiplatelet therapy with drug-eluting stents study). The American Journal of Cardiology, 120, 917–923.

3. Mangiacapra, F., Colaiori, I., Ricottini, E., Creta, A., Di Gioia, G., Cavallari, I., et al. (2018). Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: A landmark analysis. Journal of Thrombosis and Thrombolysis, 45, 496–503.

4. Malmberg, K., Yusuf, S., Gerstein, H. C., Brown, J., Zhao, F., Hunt, D., et al. (2000). Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (organization to assess strategies for ischemic syndromes) registry. Circulation, 102, 1014–1019.

5. Rivas Rios, J. R., Franchi, F., Rollini, F., & Angiolillo, D. J. (2018). Diabetes and antiplatelet therapy: From bench to bedside. Cardiovasc Diagn Ther, 8, 594–609.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD;JACC: Basic to Translational Science;2024-07

2. The Genetic Risk Score with Variants at PDGFs and PDGFRB for the Risk of Major Cardiovascular Adverse Events in Patients with Coronary Artery Disease;2024-05-10

3. Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status;The American Journal of Cardiology;2022-05

4. Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients;Journal of Cardiovascular Medicine;2021-09-20

5. Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes;Medicine;2021-04-02